A phase I trial of combined tivozanib (AV-951) and temsirolimus therapy in patients (pts) with renal cell carcinoma (RCC).
Fairooz F. Kabbinavar
No relevant relationships to disclose
Sandy Srinivas
No relevant relationships to disclose
Ralph J. Hauke
No relevant relationships to disclose
Robert J. Amato
No relevant relationships to disclose
Brooke Esteves
No relevant relationships to disclose
Reena Dhillon
No relevant relationships to disclose
Monette M. Cotreau
No relevant relationships to disclose
Mohammed Al-Adhami
No relevant relationships to disclose
Pankaj Bhargava
No relevant relationships to disclose
Mayer N. Fishman
No relevant relationships to disclose